Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 04.01.2024
Formycon AG
Press Release // January 04, 2024
Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference
Munich, Germany – Formycon AG (FSE: FYB), a leading, independent developer of high-quality biosimilars, today announced that Formycon CEO Dr. Stefan Glombitza will present at the upcoming 42nd Annual J.P. Morgan Healthcare Conference on T [ … ]
Thu, 04.01.2024
Kaplan Fox & Kilsheimer LLP
DRIVEN BRANDS INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Driven Brands Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY – January 4, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Driven Brands Holdings, Inc. (“Driven Brand [ … ]
Thu, 04.01.2024
Kaplan Fox & Kilsheimer LLP
INSPIRE MEDICAL INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies Inspire Medical Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY – January 4, 2024 – Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of Inspire Medical Systems, Inc. (“Inspire Medical” or the “Co [ … ]
Thu, 04.01.2024
JPMorgan ETFs (Ireland) ICAV
COMPANY ANNOUNCEMENT
For Immediate Release
04 January 2024
JPMorgan ETFs (Ireland) ICAV
RE: Dividends
The Directors of JPMorgan ETFs (Ireland) ICAV (the "Company") wish to announce the following dividends which are ex dividend as of the 11 January 2024, record date as of the 12 J [ … ]
Thu, 04.01.2024
Gerresheimer AG
Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy
Subcutaneous administration of oncology drugs with digital therapy support
Integrating Gx SensAir drug delivery device with Aptar's Digital Health platform
Solution aims to improve the patient experience and quality of life of cancer patients
D [ … ]
Thu, 04.01.2024
NEON EQUITY AG
NEON EQUITY AG supports GORE German Office Real Estate in structuring and implementing the non-cash capital increase
Frankfurt am Main, January 04, 2024 - NEON EQUITY AG (NEON EQUITY ISIN: DE000A3DW408), a founder-led investor and growth enabler, is acting as advisor to GORE German Office Real Estate AG ("GORE") on the structuring and implement [ … ]
Thu, 04.01.2024
u-blox AG
u-blox AG
/ Key word(s): Product Launch
u-blox module unlocks new automotive use cases 04.01.2024 / 10:04 CET/CEST
The new u-blox JODY-W6 module features concurrent dual-band Wi-Fi 6E and Bluetooth® LE Audio and operates even in high temperatures.
Thalwil, Switzerland – January 4, 2024 – u-blox (SIX:UBXN), a global pro [ … ]
Thu, 04.01.2024
Nordea Bank Abp
Nordea Bank Abp
/ Key word(s): Transaction in Own Shares
Nordea Bank Abp: Repurchase of own shares on 03.01.2024
04.01.2024 / 09:20 CET/CEST
Nordea Bank Abp: Repurchase of own shares on 03.01.2024
Nordea Bank Abp
Stock exchange release - Changes in company's own shares
03.01.2024 at 22.30 EET
Nordea Bank Abp (LEI: 529 [ … ]
Thu, 04.01.2024
Rautenberg & Company GmbH
Rautenberg & Company strengthens partnership with Eike Gerrit Büllingen and continues to grow its integrated service offering in Germany and abroad
Düsseldorf/Frankfurt, 4 January 2024 – The Strategy and Corporate Finance advisory firm Rautenberg & Company has welcomed Eike Gerrit Büllingen to its partnership. Büllingen, an experienced [ … ]
Thu, 04.01.2024
ABIVAX
Abivax 2024 Financial Communication Calendar
PARIS, France, January 4, 2024, 8:30 a.m. CET – Abivax SA (Euronext Paris & Nasdaq: ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chro [ … ]